SCHEDULE 13GAccepted Feb 10, 11:36 AM ET
Avalo Therapeutics, Inc. SCHEDULE 13G
Accepted (ET)
11:36 AM
Feb 10, 2026
Filed
Feb 10, 2026
Documents
1
Size
8.2 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.